FDA Fast-Tracks Facility Approvals 

Healthcare Packaging recently published an article on the FDA’s new PreCheck program, which is designed to accelerate approvals for US-based pharmaceutical manufacturing facilities. By offering earlier regulatory guidance, PreCheck aims to reduce uncertainty, encourage investment in domestic infrastructure, and strengthen the nation’s drug supply chain. 

The article features commentary from Project Farma CEO Anshul Mangal, who explains that greater regulatory predictability can influence how boards and investors allocate capital. This clarity, he notes, could unlock more aggressive investment in US facilities, helping ensure critical therapies are manufactured closer to home. 

Click here to read the full article, FDA Launches PreCheck to Accelerate Domestic Drug Facility Approvals